Opus Genetics
company
About
Opus Genetics is a gene therapy company for ultra-rare blinding conditions.
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $19M
- Industries
- Health Care,Health Diagnostics,Wellness
- Founded date
- Jan 1, 2004
- Operating Status
- Active
Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$19M
Opus Genetics has raised a total of
$19M
in funding over 2 rounds. Their latest funding was raised on
Sep 22, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 22, 2021 | Seed | $19M | 1 |
Retinal Degeneration Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Opus Genetics is funded by 1 investors.
Retinal Degeneration Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Retinal Degeneration Fund
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
